India’s Sun Pharma to buy Organon for $11.75 billion, signals global expansion beyond generics - Firstpost
India’s Sun Pharma to buy Organon for $11.75 billion, signals global expansion beyond generics Firstpost
ORIGINAL SOURCE →via M&A News (GN)
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · IN
- [CONFLICT] VC founder outlines why he’s doubling down on Indian deeptech
- [CONFLICT] Gold, silver rates on April 27: Check latest prices for 24K, 22K, 18K in Delhi, Mumbai, Chennai, Kolkata - Business Today
- [TECH] Indian ecommerce firms build agentic AI storefronts
- [FINANCE] Silver prices fall in India as strong dollar, rising oil prices, and Fed rate fears pressure metals - Mint
- [CONFLICT] Making India’s numbers count again
- [CONFLICT] Deepika Padukone, Ranveer Singh take daughter Dua to her first show in Mumbai